Dejana Braithwaite, PhD, MS

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address550 16th. Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral StudiesGraduate Division
    University of Cambridge, EnglandPhD, Cancer Epidemiology2004Faculty of Clinical Medicine
    University of LondonMSc, Public Health 2000School of Medicine
    London Guildhall UniversityBSc, Psychology1998School of Health Sciences
    Collapse Awards and Honors
    American Cancer Society2012  - 2017Mentored Research Scholar
    Susan Komen for the Cure2012  - 2015Research Catalyst Award
    American Society for Preventive Oncology/Prevent Cancer Foundation2004  - 2006Cancer Prevention Fellow

    Collapse Research 
    Collapse Research Activities and Funding
    Comorbidity and screening outcomes among older women undergoing mammography
    NIH R01CA207361Jan 1, 2016 - Dec 31, 2020
    Role: Principal Investigator
    Etiology of breast development in the BCERC network: role of socioeconomic status
    NIH R03CA143936Sep 30, 2009 - Aug 31, 2011
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over the life course and obesity: Systematic review and meta-analysis. PLoS One. 2017; 12(5):e0177151. PMID: 28510579.
      View in: PubMed
    2. Ahern TP, Sprague BL, Bissell MC, Miglioretti DL, Buist DS, Braithwaite D, Kerlikowske K. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiol Biomarkers Prev. 2017 Jun; 26(6):938-944. PMID: 28096200.
      View in: PubMed
    3. Akinyemiju T, Ogunsina K, Sakhuja S, Ogbhodo V, Braithwaite D. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE). BMJ Open. 2016 Nov 22; 6(11):e012753. PMID: 27881528.
      View in: PubMed
    4. Akinyemiju T, Ogunsina K, Okwali M, Sakhuja S, Braithwaite D. Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE). Int J Cancer. 2017 Feb 15; 140(4):777-787. PMID: 27813060.
      View in: PubMed
    5. Demb J, Allen I, Braithwaite D. Utilization of screening mammography in older women according to comorbidity and age: protocol for a systematic review. Syst Rev. 2016 Oct 04; 5(1):168. PMID: 27716433.
      View in: PubMed
    6. Din N, Allen IE, Satariano WA, Demb J, Braithwaite D. Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study. Breast Dis. 2016 Jul 28; 36(2-3):77-89. PMID: 27662274.
      View in: PubMed
    7. Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson AN, Wernli KJ, Onega T, et al. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 Aug; 89:169-77. PMID: 27261409; PMCID: PMC4969188 [Available on 08/01/17].
    8. Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R Hoag J, Gonsalves L, L Salner A, Zarfos K, Andemariam B, Stevens RG, G Dugan A, Pensa M, A Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes Control. 2016 May; 27(5):627-36. PMID: 27000206.
      View in: PubMed
    9. Braithwaite D, Demb J, Henderson LM. Optimal breast cancer screening strategies for older women: current perspectives. Clin Interv Aging. 2016; 11:111-25. PMID: 26893548; PMCID: PMC4745843.
    10. Braithwaite D, Walter LC, Izano M, Kerlikowske K. Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses. J Gen Intern Med. 2016 May; 31(5):561-72. PMID: 26831305; PMCID: PMC4835373 [Available on 05/01/17].
    11. Izano M, Wei EK, Tai C, Swede H, Gregorich S, Harris TB, Klepin H, Satterfield S, Murphy R, Newman AB, Rubin SM, Braithwaite D. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study. Int J Cancer. 2016 Mar 01; 138(5):1118-28. PMID: 26413860; PMCID: PMC4955608 [Available on 03/01/17].
    12. Henderson LM, O'Meara ES, Braithwaite D, Onega T. Performance of digital screening mammography among older women in the United States. Cancer. 2015 May 01; 121(9):1379-86. PMID: 25537958; PMCID: PMC4409463.
    13. Izano M, Satariano WA, Hiatt RA, Braithwaite D. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study. Cancer Med. 2015 Feb; 4(2):315-24. PMID: 25511535; PMCID: PMC4329014.
    14. Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2613-7. PMID: 25277796; PMCID: PMC4221505.
    15. Swede H, Andemariam B, Gregorio DI, Jones BA, Braithwaite D, Rohan TE, Stevens RG. Adverse events in cancer patients with sickle cell trait or disease: case reports. Genet Med. 2015 Mar; 17(3):237-41. PMID: 25144888.
      View in: PubMed
    16. Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, Rehkopf DH. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2078-92. PMID: 25017248.
      View in: PubMed
    17. Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? J Geriatr Oncol. 2014 Jul; 5(3):266-75. PMID: 24613574.
      View in: PubMed
    18. Izano M, Satariano WA, Hiatt RA, Braithwaite D. The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open. 2013 Oct 10; 3(10):e003232. PMID: 24114369; PMCID: PMC3796273.
    19. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67. PMID: 24037812; PMCID: PMC3935985.
    20. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41. PMID: 23845714; PMCID: PMC3919027.
    21. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308. PMID: 23843952; PMCID: PMC3699597.
    22. Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov; 28(11):1454-62. PMID: 23760741; PMCID: PMC3797353.
    23. Braithwaite D, Mandelblatt JS, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncol. 2013 Jun; 9(6):763-6. PMID: 23718292; PMCID: PMC3745823.
    24. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16. PMID: 23552817; PMCID: PMC3699693.
    25. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41. PMID: 23385442; PMCID: PMC3589257.
    26. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33. PMID: 23053660; PMCID: PMC3507472.
    27. Braithwaite D, Boffetta P, Rebbeck TR, Meyskens F. Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1606-10. PMID: 22850804.
      View in: PubMed
    28. Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25. PMID: 22573797; PMCID: PMC3470873.
    29. Rehkopf DH, Laraia BA, Segal M, Braithwaite D, Epel E. The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls. Int J Pediatr Obes. 2011 Jun; 6(2-2):e233-42. PMID: 21244233.
      View in: PubMed
    30. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 06; 102(19):1468-77. PMID: 20861456; PMCID: PMC2950169.
    31. Glasspool DW, Oettinger A, Braithwaite D, Fox J. Interactive decision support for risk management: a qualitative evaluation in cancer genetic counselling sessions. J Cancer Educ. 2010 Sep; 25(3):312-6. PMID: 20162470; PMCID: PMC2933800.
    32. Braithwaite D, Wernli KJ, Anton-Culver H, Engstrom P, Greenberg ER, Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7. PMID: 20615883.
      View in: PubMed
    33. Joseph G, Beattie MS, Lee R, Braithwaite D, Wilcox C, Metrikin M, Lamvik K, Luce J. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). J Genet Couns. 2010 Oct; 19(5):447-62. PMID: 20490636; PMCID: PMC2944955.
    34. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 01; 124(5):1213-9. PMID: 19058216.
      View in: PubMed
    35. Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009 Jul; 20(5):713-20. PMID: 19107561.
      View in: PubMed
    36. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9. PMID: 19047286.
      View in: PubMed
    37. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer. 2006; 5(1):61-75. PMID: 16528610.
      View in: PubMed
    38. Braithwaite D, Sutton S, Mackay J, Stein J, Emery J. Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detect Prev. 2005; 29(5):433-9. PMID: 16055276.
      View in: PubMed
    39. Walter FM, Emery J, Braithwaite D, Marteau TM. Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med. 2004 Nov-Dec; 2(6):583-94. PMID: 15576545; PMCID: PMC1466757.
    40. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2004 Jan 21; 96(2):122-33. PMID: 14734702.
      View in: PubMed
    41. Braithwaite D, Emery J, De Lusignan S, Sutton S. Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract. 2003 Oct; 20(5):545-51. PMID: 14507796.
      View in: PubMed
    42. Braithwaite D, Sutton S, Smithson WH, Emery J. Internet-based risk assessment and decision support for the management of familial cancer in primary care: a survey of GPs' attitudes and intentions. Fam Pract. 2002 Dec; 19(6):587-90. PMID: 12429659.
      View in: PubMed
    43. Braithwaite D, Sutton S, Steggles N . Intention to participate in predictive genetic testing for hereditary cancer: the role of attitude toward uncertainty. Psychology and Health. 2002; 6(17):761-772.
    Dejana's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP